Pfizer says its coronavirus vaccine is more than 90 percent effective

Pfizer says its coronavirus vaccine is more than 90 percent
effective 1

A coronavirus vaccine developed by Pfizer is more than 90 percent effective, according to the first look at data from a late-stage U.S. trial involving nearly 44,000 participants.

An analysis of 94 trial participants who contracted Covid-19 showed that the vaccine was 94 percent effective, the company and its partner BioNTech said in a press release Monday.

The pair added that they expect to apply to the FDA for an emergency-use authorization before the end of the month, after they have collected sufficient data on the vaccine’s safety.

The better-than-expected result is the first Phase III data from any of the four candidates now in the final stage of testing in the U.S.

Read the Full Article

Prepare Now Before its too Late

Discover where products are available & compare prices

COVID-1984: Parents Blocked from Seeing Sick Newborns by UK's Socialised Healthcare System
Global Coronavirus Cases Pass 50,000,000 With 1,250,000 Killed

You might also like
Menu